|Articles|September 1, 2003
Cosmetic botulinum toxin appealing to patients, physicians
Kansas City, KS-Incorporating cosmetic botulinum toxin type A (Botox, Botox Cosmetic, Allergan) treatment into an ophthalmic practice's realm of services can be very satisfying for patients and the practitioner, said Jemshed A. Khan, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
Achieving a new level of refractive precision: Surgical strategies
3
What changed in glaucoma care in 2025: Surgeon perspective
4
Global trial equity: How LMIC data is reshaping US ophthalmology research
5